MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 1 filers reported holding MERUS N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $859,939 | +52.5% | 36,469 | +70.3% | 0.00% | – |
| Q2 2023 | $563,832 | +259.8% | 21,414 | +151.5% | 0.00% | – |
| Q1 2023 | $156,695 | +25.6% | 8,516 | +5.6% | 0.00% | – |
| Q4 2022 | $124,766 | -12.8% | 8,065 | +13.3% | 0.00% | – |
| Q3 2022 | $143,000 | -8.3% | 7,120 | +2.9% | 0.00% | – |
| Q2 2022 | $156,000 | -10.9% | 6,918 | +4.4% | 0.00% | – |
| Q1 2022 | $175,000 | -17.1% | 6,627 | 0.0% | 0.00% | – |
| Q4 2021 | $211,000 | +77.3% | 6,627 | +22.1% | 0.00% | – |
| Q3 2021 | $119,000 | +376.0% | 5,427 | +352.2% | 0.00% | – |
| Q2 2021 | $25,000 | 0.0% | 1,200 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,424,000 | 19.47% |
| BVF INC/IL | 7,285,071 | $152,185,000 | 5.71% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 244,713 | $5,112,000 | 2.79% |
| Burrage Capital Management LLC | 130,683 | $2,730,000 | 2.21% |
| MPM BioImpact LLC | 700,879 | $14,641,000 | 1.84% |
| Sofinnova Investments, Inc. | 1,311,039 | $27,388,000 | 1.65% |
| Octagon Capital Advisors LP | 200,000 | $4,178,000 | 1.57% |
| Boxer Capital, LLC | 1,900,000 | $39,691,000 | 1.35% |
| DAFNA Capital Management LLC | 157,841 | $3,297,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,113,706 | $23,265,000 | 0.34% |